| 发布于: | 雪球 | 转发：0 | 回复：4 | 喜欢：0 |
$荣昌生物(SH688331)$ $恒瑞医药(SH600276)$ RC48的3期 是不是黄了，都3年多了？？？？
WOW，进入3期了，9/22开始入组，L1 UC with HER2+(包括低表达)
An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination With Pembrolizumab Versus Chemotherapy in Subjects With Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma That Expresses HER2 (IHC 1+ and Greater) $荣昌生物(SH688331)$
Seagen开了两个临床，48单药，还有48+k药，seagen Q3的研发优先级将LV下调，48排在第一位